Author:
Verleyen Wim,Langdon Simon P.,Faratian Dana,Harrison David J.,Smith V. Anne
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Patani, N., Martin, L.-A. & Dowsett, M. Biomarkers for the clinical management of breast cancer: International perspective. Int. J. Cancer 133, 1–13 (2013).
2. Marquez, R. T. et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium and colon. Human Cancer Biology 11, 6116–6126 (2005).
3. Santin, A. D. et al. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling. Brit. J. Cancer 90, 1814–1824 (2004).
4. Albain, K. et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal, node-positive, estrogen receptor-positive breast cancer. Lancet Oncol. 11, 55–65 (2010).
5. Schwartz, D. R. et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 62, 4722–4729 (2002).